ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 148 filers reported holding ARCUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,145 | +4.7% | 3,295 | +18.5% | 0.00% | 0.0% |
| Q2 2023 | $56,482 | +11.3% | 2,781 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $50,725 | -21.9% | 2,781 | -11.4% | 0.00% | 0.0% |
| Q4 2022 | $64,915 | -17.2% | 3,139 | +4.8% | 0.00% | -25.0% |
| Q3 2022 | $78,375 | +3.2% | 2,996 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $75,919 | -19.7% | 2,996 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $94,554 | -80.7% | 2,996 | -75.3% | 0.00% | -57.1% |
| Q4 2021 | $490,618 | +16.1% | 12,123 | 0.0% | 0.01% | +16.7% |
| Q3 2021 | $422,729 | +27.0% | 12,123 | 0.0% | 0.01% | +20.0% |
| Q2 2021 | $332,898 | +5.1% | 12,123 | +7.5% | 0.01% | 0.0% |
| Q1 2021 | $316,658 | +3.3% | 11,277 | -4.5% | 0.01% | 0.0% |
| Q4 2020 | $306,510 | +51.5% | 11,807 | 0.0% | 0.01% | +25.0% |
| Q3 2020 | $202,372 | -28.5% | 11,807 | +3.2% | 0.00% | -20.0% |
| Q2 2020 | $283,174 | +82.6% | 11,446 | +2.5% | 0.01% | +66.7% |
| Q1 2020 | $155,040 | +54.8% | 11,170 | +12.7% | 0.00% | +50.0% |
| Q4 2019 | $100,142 | -4.7% | 9,915 | -14.1% | 0.00% | 0.0% |
| Q3 2019 | $105,069 | +14.5% | 11,546 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $91,791 | -27.4% | 11,546 | +14.0% | 0.00% | 0.0% |
| Q1 2019 | $126,461 | +2.5% | 10,125 | -11.6% | 0.00% | 0.0% |
| Q4 2018 | $123,413 | – | 11,459 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |